Avantor Investor Day Presentation Deck

By the numbers: Biopharma Enabling life-altering breakthrough treatments to improve patient outcomes AVANTOR EXPOSURE¹ ~$3B 2020 AVANTOR SALES 50% OF REVENUE INDUSTRY OVERVIEW $38B TOTAL ADDRESSABLE MARKET (TAM)² Navantor™ +HSD 123 LONG-TERM GROWTH 1. FY20 revenue Market size per company estimates 3. FY21 estimates, excluding pending M&A 1. RESEARCH & DEVELOPMENT MSD Growth Rate ~55% of Biopharma Revenue³ AVANTOR FOCUS AREAS 2. CLINICAL & BIOREPOSITORY HSD-DD Growth Rate ~10% of Biopharma Revenue³ 3. BIOPRODUCTION DD Growth Rate ~35% of Biopharma Revenue³ 22

View entire presentation